{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:10:37Z","timestamp":1786990237413,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ibneur.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T01:52:40Z","timestamp":1612576360000},"page":"109-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review"],"prefix":"10.1016","volume":"10","author":[{"given":"Esraa","family":"Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willias","family":"Masocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2021.01.004_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","article-title":"Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial","volume":"68","author":"Abrams","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ibneur.2021.01.004_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tips.2014.03.001","article-title":"COX-2-derived endocannabinoid metabolites as novel inflammatory mediators","volume":"35","author":"Alhouayek","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ibneur.2021.01.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104822","article-title":"Cannabis sativa: much more beyond \u0394(9)-tetrahydrocannabinol","volume":"157","author":"Alves","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ibneur.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/molecules25010106","article-title":"\u03b2-Caryophyllene, a CB2-receptor-selective phytocannabinoid, suppresses mechanical allodynia in a mouse model of antiretroviral-induced neuropathic pain","volume":"25","author":"Aly","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ibneur.2021.01.004_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/phcfm.v10i1.1711","article-title":"Priority areas for cannabis and cannabinoid product research in South Africa","volume":"10","author":"Augustine","year":"2018","journal-title":"Afr. J. Prim. Health Care. Fam. Med."},{"key":"10.1016\/j.ibneur.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","article-title":"Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.ibneur.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/092986607780090829","article-title":"Critical enzymes involved in endocannabinoid metabolism","volume":"14","author":"Basavarajappa","year":"2007","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ibneur.2021.01.004_bib8","article-title":"Cannabis tourist destinations: risk for vulnerable travellers with pre-existing mental disorders","volume":"27","author":"Bonny-Noach","year":"2019","journal-title":"J. Travel Med."},{"key":"10.1016\/j.ibneur.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamainternmed.2017.5308","article-title":"The Achilles heel of medical cannabis research-inadequate blinding of placebo-controlled trials","volume":"178","author":"Casarett","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ibneur.2021.01.004_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2021.01.004_bib11","series-title":"Neurobiology of Disease","first-page":"871","article-title":"80 - Toxic and drug-induced neuropathies","author":"Cavaletti","year":"2007"},{"key":"10.1016\/j.ibneur.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1745-7254.2007.00578.x","article-title":"Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats","volume":"28","author":"Chu","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ibneur.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1054773809334958","article-title":"Marijuana effectiveness as an HIV self-care strategy","volume":"18","author":"Corless","year":"2009","journal-title":"Clin. Nurs. Res."},{"key":"10.1016\/j.ibneur.2021.01.004_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024793","article-title":"Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation","volume":"9","author":"Costiniuk","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ibneur.2021.01.004_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02944294","article-title":"Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs","volume":"25","author":"Daoud","year":"1999","journal-title":"Compr. Ther."},{"issue":"Suppl 1","key":"10.1016\/j.ibneur.2021.01.004_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2165\/00003495-198800351-00004","article-title":"Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment","volume":"35","author":"Daymond","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.ibneur.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","article-title":"Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal","volume":"77","author":"Deng","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ibneur.2021.01.004_bib19","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2021.01.004_bib20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ibneur.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/QAI.0b013e318273ab3a","article-title":"Medicinal and recreational marijuana use among HIV-infected women in the Women\u2019s Interagency HIV Study (WIHS) cohort, 1994-2010","volume":"61","author":"D\u02bcsouza","year":"2012","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ibneur.2021.01.004_bib23","article-title":"Cannabidivarin for HIV\u2010associated neuropathic pain: a randomized, blinded, controlled clinical trial","author":"Eibach","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ibneur.2021.01.004_bib24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial","volume":"34","author":"Ellis","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ibneur.2021.01.004_bib25","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/cam4.816","article-title":"\u03b2-caryophyllene and \u03b2-caryophyllene oxide-natural compounds of anticancer and analgesic properties","volume":"5","author":"Fidyt","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.ibneur.2021.01.004_bib26","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10129","article-title":"The endocannabinoid system, cannabinoids, and pain","volume":"4","author":"Fine","year":"2013","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.ibneur.2021.01.004_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/1475636021000049726","article-title":"Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner","volume":"18","author":"Fowler","year":"2003","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ibneur.2021.01.004_bib28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14737175.2020.1776610","article-title":"Cannabis and multiple sclerosis","volume":"20","author":"Fragoso","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.ibneur.2021.01.004_bib29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ibneur.2021.01.004_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031111","article-title":"Discovery of prostamide F2\u03b1 and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability","volume":"7","author":"Gatta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ibneur.2021.01.004_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ncl.2008.04.001","article-title":"Diagnosis and management of HIV-associated neuropathy","volume":"26","author":"Gonzalez-Duarte","year":"2008","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.ibneur.2021.01.004_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.phrs.2012.10.013","volume":"67","author":"Guindon","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ibneur.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2760(95)00157-8","article-title":"Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor","volume":"1259","author":"Hampson","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ibneur.2021.01.004_bib35","first-page":"e1","article-title":"Patterns and correlates of cannabis use among individuals with HIV\/AIDS in Maritime Canada","volume":"25","author":"Harris","year":"2014","journal-title":"Can. J. Infect. Dis. Med. Microbiol. J. canadien maladies infectieuses microbiologie medicale"},{"key":"10.1016\/j.ibneur.2021.01.004_bib36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ejp.1297","article-title":"European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management","volume":"22","author":"H\u00e4user","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","article-title":"Cannabidivarin is anticonvulsant in mouse and rat","volume":"167","author":"Hill","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: a clinical review","volume":"2","author":"Hill","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ibneur.2021.01.004_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pain.2012.12.023","article-title":"A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy","volume":"154","author":"Huang","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ibneur.2021.01.004_bib41","unstructured":"IASP, 2014\u20132015. Epidemiology of Neuropathic Pain: How Common is Neuropathic Pain, and What is Its Impact? Found at https:\/\/s3.amazonaws.com\/rdcms-iasp\/files\/production\/public\/AM\/Images\/GYAP\/Epidemiology%20of%20Neuropathic%20Pain.pdf."},{"key":"10.1016\/j.ibneur.2021.01.004_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/COH.0000000000000103","article-title":"HIV neuropathy","volume":"9","author":"Kaku","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ibneur.2021.01.004_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2014.09.008","article-title":"JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy","volume":"90","author":"Khasabova","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ibneur.2021.01.004_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612043453081","article-title":"Oxidative metabolism of endocannabinoids by COX2","volume":"10","author":"Kozak","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ibneur.2021.01.004_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpainsymman.2013.02.018","article-title":"A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain","volume":"47","author":"Lynch","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ibneur.2021.01.004_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00166","article-title":"Metabolism of the endocannabinoid anandamide: open questions after 25 years","volume":"10","author":"Maccarrone","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ibneur.2021.01.004_bib47","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1007\/BF02854900","article-title":"Cannabinoid receptors and endocannabinoids: evidence for new players","volume":"8","author":"Mackie","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.ibneur.2021.01.004_bib48","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ibneur.2021.01.004_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jphs.2019.02.007","article-title":"Indomethacin plus minocycline coadministration relieves chemotherapy and antiretroviral drug-induced neuropathic pain in a cannabinoid receptors-dependent manner","volume":"139","author":"Masocha","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ibneur.2021.01.004_bib50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2021.01.004_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAI.0000000000001998","article-title":"Marijuana use is not associated with changes in opioid prescriptions or pain severity among people living with HIV and chronic pain","volume":"81","author":"Merlin","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ibneur.2021.01.004_bib52","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ibneur.2021.01.004_bib53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1155\/2014\/754693","article-title":"Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society","volume":"19","author":"Moulin","year":"2014","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.ibneur.2021.01.004_bib54","first-page":"844","article-title":"Pharmacologic management of chronic neuropathic pain: review of the Canadian Pain Society consensus statement","volume":"63","author":"Mu","year":"2017","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ibneur.2021.01.004_bib55","article-title":"Cannabis\u2010based medicines for chronic neuropathic pain in adults","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ibneur.2021.01.004_bib56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fphar.2017.00136","article-title":"Antihyperalgesic activities of endocannabinoids in a mouse model of antiretroviral-induced neuropathic pain","volume":"8","author":"Munawar","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2021.01.004_bib58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/bph.12411","article-title":"Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS","volume":"171","author":"Murataeva","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3810\/pgm.2014.07.2787","article-title":"Role of indomethacin in acute pain and inflammation management: a review of the literature","volume":"126","author":"Nalamachu","year":"2014","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ibneur.2021.01.004_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.neuropharm.2014.11.024","article-title":"Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy","volume":"95","author":"Nasirinezhad","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2021.01.004_bib61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"N\u00fa\u00f1ez","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.ibneur.2021.01.004_bib62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","article-title":"Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial","volume":"133","author":"Nurmikko","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib63","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ibneur.2021.01.004_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1521\/aeap.2018.30.2.169","article-title":"Frequency of cannabis use and medical cannabis use among persons living with HIV in the United States: findings from a nationally representative sample","volume":"30","author":"Pacek","year":"2018","journal-title":"AIDS Educ. Prev."},{"key":"10.1016\/j.ibneur.2021.01.004_bib65","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/525S10a","article-title":"A potted history","volume":"525","author":"Pain","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2021.01.004_bib66","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00210-018-1533-1","article-title":"Supraspinal interaction between HIV-1-gp120 and cannabinoid analgesic effectiveness","volume":"391","author":"Palma","year":"2018","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib67","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1038\/srep10541","article-title":"Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: involvement of cannabinoid CB1 receptors","volume":"5","author":"Parvathy","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2021.01.004_bib68","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2458-8-255","article-title":"Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa","volume":"8","author":"Peltzer","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ibneur.2021.01.004_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014433","article-title":"Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ibneur.2021.01.004_bib70","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0021-9258(18)33114-4","article-title":"Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate","volume":"258","author":"Prescott","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ibneur.2021.01.004_bib71","unstructured":"Putri, D., 2020. Cannabis rescheduling: what could it mean Africa. London: International Drug Policy Consortium and Translational institute), https:\/\/idpc.net\/publications\/2020\/06\/cannabisrescheduling-what-could-it-mean-for-africa."},{"key":"10.1016\/j.ibneur.2021.01.004_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.japh.2019.07.015","article-title":"The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: a systematic review and network meta-analysis","volume":"60","author":"Rabgay","year":"2020","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.ibneur.2021.01.004_bib73","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","article-title":"Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside","volume":"6","author":"Rahn","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ibneur.2021.01.004_bib74","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/cr2002799","article-title":"Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways","volume":"111","author":"Rouzer","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ibneur.2021.01.004_bib75","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.bcp.2003.12.003","article-title":"Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes","volume":"67","author":"Saario","year":"2004","journal-title":"Biochemical Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib76","first-page":"243","article-title":"HIV-related neuropathy: current perspectives","volume":"5","author":"Sch\u00fctz","year":"2013","journal-title":"HIV\/AIDS"},{"key":"10.1016\/j.ibneur.2021.01.004_bib77","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/j.1532-2149.2013.00445.x","article-title":"A double-blind, randomized, placebo-controlled, parallel group study of THC\/CBD spray in peripheral neuropathic pain treatment","volume":"18","author":"Serpell","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1260353","article-title":"Antiallodynic effects of cannabinoid receptor 2 (CB2R) agonists on retrovirus infection-induced neuropathic pain","volume":"2019","author":"Sheng","year":"2019","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.ibneur.2021.01.004_bib79","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/aid.2020.0128","article-title":"The current state of HIV and aging: findings presented at the 10th International Workshop on HIV and Aging","volume":"36","author":"Shiau","year":"2020","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ibneur.2021.01.004_bib80","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1080\/10826084.2017.1416408","article-title":"Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain","volume":"53","author":"Sohler","year":"2018","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.ibneur.2021.01.004_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2006.02.042","article-title":"Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation","volume":"1085","author":"Song","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2021.01.004_bib82","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ibneur.2021.01.004_bib83","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1445-5994.2003.00401.x","article-title":"Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand","volume":"33","author":"Taylor","year":"2003","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ibneur.2021.01.004_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110456","article-title":"Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain","volume":"129","author":"Thomas","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ibneur.2021.01.004_bib85","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.pain.2012.06.024","article-title":"An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain","volume":"153","author":"Toth","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02791072.1981.10471447","article-title":"The religious and medicinal uses of Cannabis in China, India and Tibet","volume":"13","author":"Touw","year":"1981","journal-title":"J Psychoact. Drugs"},{"key":"10.1016\/j.ibneur.2021.01.004_bib87","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.clinthera.2017.01.016","article-title":"Effects on spasticity and neuropathic pain of an oral formulation of \u03b49-tetrahydrocannabinol in patients with progressive multiple sclerosis","volume":"40","author":"van Amerongen","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ibneur.2021.01.004_bib88","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2021.01.004_bib89","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200519040-00005","article-title":"HIV-associated neuropathic pain","volume":"19","author":"Verma","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ibneur.2021.01.004_bib90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0000000000002248","article-title":"Pain in clients attending a South African voluntary counseling and testing center was frequent and extensive but did not depend on HIV status","volume":"83","author":"Wadley","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ibneur.2021.01.004_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pain.2007.02.015","article-title":"Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy","volume":"133","author":"Wallace","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib92","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/brain\/awm195","article-title":"Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain","volume":"130","author":"Wallace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib93","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.bjp.0707326","article-title":"The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy","volume":"151","author":"Wallace","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib94","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pain.2012.02.015","article-title":"Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels","volume":"153","author":"Wilkerson","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.ibneur.2021.01.004_bib95","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11481-020-09905-y","article-title":"Analgesic effects of cannabinoids for chronic non-cancer pain: a systematic review and meta-analysis with meta-regression","volume":"15","author":"Wong","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ibneur.2021.01.004_bib96","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jpainsymman.2004.07.011","article-title":"Cannabis use in HIV for pain and other medical symptoms","volume":"29","author":"Woolridge","year":"2005","journal-title":"J. Pain Symptom Manag."},{"issue":"3","key":"10.1016\/j.ibneur.2021.01.004_bib97","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1108\/JTF-10-2018-0064","article-title":"Cannabis and Tourism: A Future Uk Industry Perspective","volume":"5","author":"Wright","year":"2019","journal-title":"J. Tourism Fut."},{"key":"10.1016\/j.ibneur.2021.01.004_bib98","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/363215a0","article-title":"Early medical use of cannabis","volume":"363","author":"Zlas","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2021.01.004_bib99","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242121000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242121000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T12:12:37Z","timestamp":1742040757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242121000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":99,"alternative-id":["S2667242121000051"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2021.01.004","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}